The global epigenetics diagnostics market size is accounted at USD 19.46 billion in 2025 and is forecasted to hit around USD 67.26 billion by 2034, representing a CAGR of 14.81% from 2025 to 2034. The North America market size was estimated at USD 6.59 billion in 2024 and is expanding at a CAGR of 14.85% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Epigenetics Diagnostics Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Epigenetics Diagnostics Market Revenue and Volume, by Product
8.1.1 Reagents
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Kits
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Instruments
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Enzymes
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Services
8.1.5.1. Market Revenue and Volume Forecast
9.1. Epigenetics Diagnostics Market Revenue and Volume, by Application
9.1.1. Oncology
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. NonOncology
9.1.2.1. Market Revenue and Volume Forecast
10.1. Epigenetics Diagnostics Market Revenue and Volume, by Technology
10.1.1. DNA Methylation
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Histone Methylation
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Histone Acetylation
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Large NonCoding RNA
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Microrna Modification
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Chromatin Structures
10.1.6.1. Market Revenue and Volume Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product
11.1.2. Market Revenue and Volume Forecast, by Application
11.1.3. Market Revenue and Volume Forecast, by Technology
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product
11.1.4.2. Market Revenue and Volume Forecast, by Application
11.1.4.3. Market Revenue and Volume Forecast, by Technology
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product
11.1.5.2. Market Revenue and Volume Forecast, by Application
11.1.5.3. Market Revenue and Volume Forecast, by Technology
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product
11.2.2. Market Revenue and Volume Forecast, by Application
11.2.3. Market Revenue and Volume Forecast, by Technology
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product
11.2.4.2. Market Revenue and Volume Forecast, by Application
11.2.4.3. Market Revenue and Volume Forecast, by Technology
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product
11.2.5.2. Market Revenue and Volume Forecast, by Application
11.2.5.3. Market Revenue and Volume Forecast, by Technology
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product
11.2.6.2. Market Revenue and Volume Forecast, by Application
11.2.6.3. Market Revenue and Volume Forecast, by Technology
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product
11.2.7.2. Market Revenue and Volume Forecast, by Application
11.2.7.3. Market Revenue and Volume Forecast, by Technology
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product
11.3.2. Market Revenue and Volume Forecast, by Application
11.3.3. Market Revenue and Volume Forecast, by Technology
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product
11.3.4.2. Market Revenue and Volume Forecast, by Application
11.3.4.3. Market Revenue and Volume Forecast, by Technology
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product
11.3.5.2. Market Revenue and Volume Forecast, by Application
11.3.5.3. Market Revenue and Volume Forecast, by Technology
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product
11.3.6.2. Market Revenue and Volume Forecast, by Application
11.3.6.3. Market Revenue and Volume Forecast, by Technology
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product
11.3.7.2. Market Revenue and Volume Forecast, by Application
11.3.7.3. Market Revenue and Volume Forecast, by Technology
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product
11.4.2. Market Revenue and Volume Forecast, by Application
11.4.3. Market Revenue and Volume Forecast, by Technology
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product
11.4.4.2. Market Revenue and Volume Forecast, by Application
11.4.4.3. Market Revenue and Volume Forecast, by Technology
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product
11.4.5.2. Market Revenue and Volume Forecast, by Application
11.4.5.3. Market Revenue and Volume Forecast, by Technology
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product
11.4.6.2. Market Revenue and Volume Forecast, by Application
11.4.6.3. Market Revenue and Volume Forecast, by Technology
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product
11.4.7.2. Market Revenue and Volume Forecast, by Application
11.4.7.3. Market Revenue and Volume Forecast, by Technology
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product
11.5.2. Market Revenue and Volume Forecast, by Application
11.5.3. Market Revenue and Volume Forecast, by Technology
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product
11.5.4.2. Market Revenue and Volume Forecast, by Application
11.5.4.3. Market Revenue and Volume Forecast, by Technology
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product
11.5.5.2. Market Revenue and Volume Forecast, by Application
11.5.5.3. Market Revenue and Volume Forecast, by Technology
12.1. Roche Diagnostics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thermo Fisher Scientific, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Eisai Co. Ltd.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Novartis AG
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Element Biosciences, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Dovetail Genomics LLC.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Illumina, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. ValiRx Plc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Abcam plc
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client